Tune in for a fun episode, where we adapt the popular game to the healthcare industry.

How it happens, how to prevent it, and what to do if it's already happened.

It's a good time to think back on this year’s highs and lows in the energy sector – or, the lows and lowers.

On this very special episode, our energy team compare their fantasy-energy-draft portfolios, some of the most dramatic and unexpected news stories that played out this year from Kinder Morgan’s soap opera to the U.S. export sanction shift, just how accurate predictions from earlier this year turned out to be, and what everyone’s learned from investing in and following this troubled sector this year.

We're talking about stocks that investors might like to wake up owning on Christmas morning.

What Walt Disney, Netflix, and Boston Beer investors can learn from young generation's spending habits.

Well-meaning family and friends might tell one of these very nuggets over the holidays – do you know which ones to seriously consider?

Updates on Google’s EC issues and the CRB’s Web IV ruling and its impact on Pandora for the final tech show of 2015.

After securing an extension of the investment tax credit, things are looking awfully bright for the solar industry. Plus, Federal Reserve Interest Rate hikes, lifting oil export ban, and more troubled oil producers, oh my!

There were a record number of healthcare deals in 2015. Here are some of our favorites.

M&A activity continues to pick up in the consumer goods sector with this $15 billion deal.

Knowledge is a gift that will last forever. Here are four of our favorite investing books for you to read or give to a loved one.

GoPro jumped this week after one analyst suggested Apple scoop it up with some of the cash it has sitting around. What should investors make of this news and M&A chatter in general?

This week’s OPEC meetings ended with shockingly few changes or agreements, Kinder Morgan dramatically cut its dividend, and two of the world’s biggest chemical companies are merging in a way that may or may not set off regulatory alarm bells.

Digging into the balance sheet of two drugmaking powerhouses to see which may be a better investment.

An international coffee conglomerate adds Keurig to its portfolio for $13.9 billion. And at Amazon, its Prime TV service just got even better.

In a rapidly changing environment, here's how a company's adaptability affects their survival. 

Breaking down IDC wearables shipment data – a look at the winners, losers, and trends in the space. Also, an explanation on how Apple and Samsung decided to bury the patent hatchet just in time for the holidays.

With the Paris climate talks in full swing, here’s a look at what lies ahead for this rapidly-changing sector.

Application for our summer 2016 internships is officially open! Check out all our openings at Careers.Fool.com

This episode we're highlighting what we think are the most significant, needle-moving drugs to hit the market this year.

Disney’s biggest cash cow is in danger as subscriber losses at ESPN accelerate. Will the other businesses be able to fill the void?

We hope you had a happy Thanksgiving! Here's a grab bag episode on Wells Fargo's sales tactics, the state of the housing market, and an end-of-year to-do list for your investment accounts.

This holiday, we’re thankful for innovation, passion, and greater purpose in the healthcare sector.

From its origins to present day, we dive into this annual tradition and its impact on the retail industry.

On this episode we talk about what 13Fs are, shorting stocks, and a Gallup poll about how well do ordinary people understand the basics of their own finances.

We tackle how new investors should think about buying stocks, what to look for in potential dividend investments, and cover mistakes some investors make by focusing on the wrong metric.

To find out our picks for the top dividend stocks in 2016, check out dividends.fool.com.

Continuing with our dividend week theme, we take a deeper dive into why its so much more difficult for energy and materials companies to maintain dividends and what investors should look for in a dividend stock that deals in commodities.

To find out our picks for the top dividend stocks in 2016, check out dividends.fool.com.

Understanding the anatomy of great dividend paying healthcare stocks, including what to look for and what to avoid. 

For our best dividend stock ideas, go to dividends.fool.com.

Retailers have sold off and that’s good news for income investors, particularly those willing to take a close look at department store operator Macy’s.

For our best dividend stock ideas, go to dividends.fool.com.

It's Dividend Week on Industry Focus and today we learn about dividend stocks in general and in the financial industry in particular.

For our best dividend stock ideas, go to dividends.fool.com.

Following earnings, several big name tech stocks took a beating. We discuss Pandora, FireEye and HP and see what's caused their dips and debate whether they can earn their way back to "buy" status.

Oil's low prices have stuck around much longer than so many originally thought. Now, more than a year later, we're starting to see companies buckle under the pressure. Our energy team looks at the implications and the lesson to learn from these companies' demise.

Exelixis has a newly approved melanoma drug hitting the market soon and Colorado voters will weigh in on universal healthcare in 2016.

Traditional apparel retailers like Macy’s and Nordstrom have limped through 2015. What is driving weakness in the sector, and what should investors watch in the latest quarter?

Tune in for discussions on the NYCB-Astoria Financial merger, New York Mellon Bank, and whether or not CEOs should live near HQ.

On this episode we talk earnings numbers, some cool stats from the conference call and check in on Facebook’s other big internet properties.

Energy results are as diverse as the industry itself, and Motley Fool’s Tyler Crowe, Taylor Muckerman and Sean O’Reilly weigh in.

Motley Fools dig into recent announcements that could impact the marijuana and hepatitis C markets next year.

On this episode we dig into Apple’s record-setting quarter, explain why the market shouldn’t have been surprised, and figure out what segments fueled the company’s great top and bottom line growth.

Oil sands are becoming more common in the energy sector, and with the amount of work it takes to clean these sands, it's no wonder the cost is so high. Shell not only dropped out of the Arctic after building up all the hype, but now they're letting go of oil sands projects, citing the company's business structure as the problem.

All the while, a "cash crunch" is enveloping the Fab Four in the oil and gas sector, but although these numbers are huge to a layperson, their cash reserves seem to be singing a different tune.

This week we're discussing Walgreens acquiring Rite Aid. Did this retail pharmacy giant play its cards right? Does an overlapping footprint mean the two retail pharmacies will step on each other’s toes? Tune in to find some answers.

As the king of retail recognizes its growing reliance on online sales, the company plans to experiment with drones to beat Amazon at its own game.

On this episode we also learn how Cheesecake Factory serves up continued success, we preview Buffalo Wild Wings' earnings release and discover a retailer who says "no" to the Black Friday shopping craze.

"Competitive Advantage" is the book where economy guru Michael Porter outlines the way to review, research, and plan when assessing an industry for a potential investment.

With big names investors such as Warren Buffett using competitive advantage as a guideline prior to investing, it's quite obvious that success is found when these tools are used.

Google and Amazon both had impressive earnings releases this week and the market sent both stocks up 10% after hours. On this episode of Industry Focus we walk through the numbers and see what segments drove growth for each company.

Glencore is known as a giant in the commodities sector, but their recent bout of bond needs has left investors fearing the worst outcome for the company.

Meanwhile, Petrobras is trying to save face as Brazilian currency takes a dive, and Tyler has a favorite stock, Enterprise Products Partners; but there's a fun fact behind this company that might have you jumping on the investment train as well.

Our guest Michael O’Neil, CEO of GetWellNetwork, shares how his company is boosting outcomes and improving experience through patient engagement.

From a division spin-off to a major celebrity partnership, investors are buying up shares of these consumer goods companies with the hope that they have found the solution to years of underperformance.

On today's episode we take a look at the performance of a few "too big to fail" banks in the most recent quarter.

Dell’s $67 billion purchase of EMC stands to be the largest acquisition in tech history, but will we look back in a few years and say it was money well spent?

Job cuts have begun for some oil companies as they attempt to bring margins to a normalized number. And as stock prices drop for oil, renewable energies seem to have little to no relation with these numbers.

On this episode, our analysts will tell you what they'll be looking for over the next month as earnings are announced for the energy sector.

Both democratic front-runners have outlined healthcare reform that could impact healthcare stocks, so let's learn more about their plans and the companies that could be affected.

Following a publicized and contentious month-long courtship, the No. 1 and No. 2 brewers are combining to create a massive entity controlling 30% of the global beer market.

Anheuser-Busch InBev and SABMiller expect to realize billions of dollars in synergies and a worldwide reach, but the combined entity still needs to clear regulatory hurdles and manage a ballooning debt balance before the union is official.

Welcome to not your typical financials podcast!

Earlier this week, Pandora announced it had acquired Ticketfly, an online ticketing company, for $450 million. Does the move make sense, and what should investors think of the company moving forward?

After several straight days of big oil price gains, are energy stocks headed back on the right track. Plus, a Challenge to Warren Buffett's energy empire and the state of energy M&A.

Biotech stocks may have fallen sharply in the past few months, but that doesn't mean that everyone of them should be avoided. In this episode, we uncork some of our best ideas for investors to buy.

We cover all-day breakfast, massive M&A deals, and standout earnings on this episode of Industry Focus.

On today's episode we're exploring the companies behind the acronym.

On this episode we break down Apple’s controversial decision to allow content blocking in iOS9 – who does it hurt most, why users should love it and how you can get enable it on your device?

From Glencore's debt scares to Shell's Arctic drilling debacle, the energy guys at Industry Focus take a look at some of the big moves from energy and commodities companies this past week.

The highly anticipated switch over to ICD-10 medical coding kicks October off and a FDA decision later in the month could move the needle at Shire Plc.

A major product launch and multi-billion dollar deals color this episode of Industry Focus.

Earnings season is coming up. Are you ready?

It’s tough to stay up to date on VR news -- in hardware, Samsung recently unveiled its update to its Gear VR headset, while loose details about a consumer-ready Oculus Rift circulate. Facebook is starting to feature immersed video content while Google is interested in  being behind the camera (so to speak).

On this episode, Motley Fool’s Dylan Lewis and Sean O’Reilly break down who is doing what in virtual reality.

Pretty soon, oil producers will need to show bankers that they are still worthy of borrowing money. So our energy guys take a look at what this could mean for companies. Plus, another mailbag question and Big Oil is turning into Big Renewables?

The Motley Fool highlights potential winners and losers in Hillary Clinton's proposed plan to curb soaring drug prices.

From streaming video and music to virtual reality and more, we round-up the latest stories from the consumer goods sector.

Listen in as we discuss Bank of America’s upcoming vote on Brian Moynihan role, the Fed doing nothing, and the current state of the US economy.

Google is under fire from Russian authorities over competitive issues and the European Union isn’t far behind. Meet the competitor that sounded the horn and learn how the decision from Russia, expected to be finalized next week, could set up Google for a tough battle in Europe.

It appears that the seeds of a slowdown in oil production have been planted, so Sean, Tyler, and Taylor sit down and discuss when those seeds will start to bear fruit.

Plus, we dip into the mailbag and Sean gets to ask a "what's puzzling me" question.

Growing use of healthcare IT offers plenty of investing opportunity, but challenges remain and that makes picking the right healthcare IT stock to buy important.

Despite being one of the most heavily shorted companies trading on the NASDAQ Composite, Sirius XM has proven satellite radio is here to stay as it launches new growth initiatives to shore up its long-term future with connected cars and SXM17. And in the world of beer, MillerCoors is feeling the pressure from increasing craft beer sales as it closes one of its eight U.S. breweries.

A primer on Social Security’s current funding situation and how it may affect you.

Christmas morning finally came for investors eager to set their eyes on the latest Apple gadgets – the company unveiled its updates for the iPhone and Apple TV lines and showed off the highly anticipated iPad Pro in its event earlier this week. What new features do these products boast and how do they fit into the market place?

While everyone else is getting ready for football season, Sean, Tyler and Taylor are drafting energy stocks this week with our first ever energy stock fantasy draft.

The diabetes pandemic and medical marijuana are two of the healthcare's biggest trends, but not all diabetes or marijuana stocks are likely to succeed. The Motley Fool's Kristine Harjes and Todd Campbell explain what you need to consider before investing in these growing markets.

Following the underwhelming debut of its Keurig 2.0, Keurig Green Mountain has pegged its future success to the Kold beverage system.

Meanwhile, Skullcandy moves forward with its expansion efforts as its multi-year turnaround seemingly takes hold. With both stocks suffering significant losses year-to-date, is this the right time for investors to buy?

While the broader market has begun to stabilize after macro concerns pushed down stocks the past two weeks, there are still several tech companies that have yet to rebound, thanks to some idiosyncratic concerns. Are these companies bargains for a reason, or do they belong on your watchlist?

On this energy edition of Industry Focus we take a look at what's going on with oil prices, how its impacting producers, and what investors can do about it.

Motley Fool's Kristine Harjes and Todd Campbell discuss whether investors ought to be buying 3 of biotech's worst performing stocks over the past month.

After years of building its subscriber base with a vast library of content, Netflix is making a risky bet that will see it lose thousands of popular movies in favor of exclusive titles. Is the company making another Qwikster-like mistake or preparing itself for a bright, new future?

Should an intangible quality like corporate culture affect how you invest?

Facebook has entered the personal assistant space, announcing testing has begun on “M,” a new digital helper nested in their Messenger app -- what does it say about the company’s plans to monetize Messenger and WhatsApp? In other tech news, new data from IDC shows Apple and Xiaomi are catching up to wearables leader Fitbit. Is the recently public company about to get pinched?

In the midst of popping and dropping markets, the Motley Fool's Kristine Harjes and contributor Todd Campbell tackle what healthcare stocks investors can buy.

Major indexes all over the world have suffered some of their steepest losses since the financial crisis over the past week. Smart investors, however, should sit tight.

Inevitable market corrections can be great opportunities. Learn how on today's Industry Focus, financials edition.

Over 30 million users from the popular online dating site have had their information leaked after Ashley Madison was hit by a cyberattack. Given the nature of the site’s business, its data breach has been widely reported on, but how does it compare to some of the biggest corporate data breaches in history and how can other companies prevent it from happening to them?

This week we dip into the mailbag to answer questions from our listeners; covering topics from natural gas vehicles, oil services sustainability, and sinking solar stocks.

Motley Fool's Kristine Harjes and contributor Todd Campbell discuss second quarter earnings winners and losers.

Sales growth has stalled out at most department stores in the past couple of years. But that's not true at Nordstrom, where revenue continues to grow at a high single-digit pace. What is Nordstrom's secret to success?

Banks are in a highly competitive industry so they constantly look for advantages -- sometimes illegal ones. Tune in to find out the details!

Google’s leadership shocked the market earlier this week when they announced the company would restructure under the holding company “Alphabet”.

It’s a savvy move that should help the tech giant focus operations, increase transparency, and keep valuable talent, but what does it mean for investors?

We have a tendency to get deep into the weeds with energy stocks on the show, so this week we decided to give a refresher on the basics of investing in energy. Plus, we tackle the big story of the week, China's currency, and pull a question from the mailbag.

Motley Fool's experts weigh in on payer pushback to new cholesterol busting medicine and surging Obamacare penalties in 2016.

The first earnings announcement for the combined entity shares the bare minimum with investors. Also, Verizon follows in T-Mobile’s footsteps as it prepares to end subsidized two-year contracts.

This episode we take a closer look at the theories and policies underlying the Greek debt crisis.

In a recent interview, Apple exec Eddy Cue said the free trial of Cupertino’s new music streaming service has a 11 million users – that’s a far cry from Spotify’s active user base of over 70 million. After some early tech setbacks and brutally critical reviews, what is the outlook for the tech giant’s new music offering?

As coal plants are slowly dying off, new regulations are being placed by the Obama administration to clear the air of carbon’s residue. 

While coal is on its way down, natural gas is gaining momentum and becoming one of the most efficient and most affordable energy resources in our nation. And Tyler Crowe takes a moment to let us in on a secret stock he’s been watching, on today’s Industry Focus, energy edition.

CVS's plan to boost prescription revenue by abandoning Tobacco might be panning out, and Regeneron's pricey new drug could become a multibillion blockbuster.

The FCC cleared the way for AT&T to complete its acquisition of DirecTV last month, creating the largest pay-TV provider in the country. Can AT&T leverage its now comprehensive suite of service offerings to jumpstart its stock price?

As he’s recently thrown his hat into the ring as a presidential candidate, The Motley Fool is diving in head first to get the full story about Trump.

Find out where Donald Trump started, and how he rose to be the man who has worked his way to the top with no intention of stopping.